Ahmet Metin Hascicek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmet Metin Hascicek has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Serkan Özcan
Izmir Katip Celebi University
2 shared publications - Akif Diri
Sağlık Bakanlığı Ankara Eğitim ve Araştırma Hastanesi Şükriye Mh., Ulucanlar Cd. No. 89, 06340 Ankara, Turkey
1 shared publication - Arif Aydın
Department of Urology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey
1 shared publication - Berat Cem Özgür
Department of Urology, Ankara Training and Research Hospital, Ankara, Turkey
1 shared publication - Eda Tokat
Department of Urology University of Health Sciences Ankara Research and Training Hospital
1 shared publication - Emre Huri
Department of Urology, Hacettepe University Faculty of Medicine, Ankara, Türkiye
1 shared publication
Latest Publications
- 7 October 2021
- Published by Wiley in Neurourology and Urodynamics
- Vol. 41 (1) , 281-289
Long‐term postoperative follow‐up results of transobturator autologous rectus fascial sling versus transobturator tension‐free vaginal tapes for female stress urinary incontinence: Randomized controlled clinical trial
Aims: To evaluate the outcomes of a new surgical technique for the treatment of stress urinary incontinence (SUI).Methods: This randomized study included 132 index patients from January 2017 to May 2021, 60 applied with autologous facia and 60 with transobturator tension‐free vaginal tape (TVT‐O). The primary endpoint was dryness (negative stress test and 0 pad use per day) and this was assessed at 3, 6, 12, and 24 months. The secondary endpoints were the International Consultation on Incontinence Questionnaire short form (ICIQ‐SF) and the urinary incontinence quality of life (QoL) at 3, 6, 12, and 24 months.Results: The dryness rate at 24 months was 92.4% (49/53) for patients with transobturator autologous rectus fascial sling (TO‐AFS) and 94.6% (53/56) for those with TVT‐O (p = 0.47). No difference was determined between the TO‐AFS and TVT‐O groups in respect of the ICIQ‐SF and QoL scores at 2 years postoperatively (p = 0.87). There were five postoperative complications in the TO‐AFS group (one urinary retention, one hematoma at suprapubic incision line, and three intermittent groin pains) and four in the TVT‐O group (four persistent groin pain) (p = 0.98).Conclusions: The objective cure rates of the 24‐month outcomes of TO‐AFS indicate that this novel surgical technique seems to be a highly effective, safe, and feasible procedure for the treatment of SUI, but further studies including long‐term follow‐up are mandatory to confirm these preliminary data.
- 7 October 2021
- Published by Wiley in Neurourology and Urodynamics
- Vol. 41 (1) , 281-289
Long‐term postoperative follow‐up results of transobturator autologous rectus fascial sling versus transobturator tension‐free vaginal tapes for female stress urinary incontinence: Randomized controlled clinical trial
Aims: To evaluate the outcomes of a new surgical technique for the treatment of stress urinary incontinence (SUI).Methods: This randomized study included 132 index patients from January 2017 to May 2021, 60 applied with autologous facia and 60 with transobturator tension‐free vaginal tape (TVT‐O). The primary endpoint was dryness (negative stress test and 0 pad use per day) and this was assessed at 3, 6, 12, and 24 months. The secondary endpoints were the International Consultation on Incontinence Questionnaire short form (ICIQ‐SF) and the urinary incontinence quality of life (QoL) at 3, 6, 12, and 24 months.Results: The dryness rate at 24 months was 92.4% (49/53) for patients with transobturator autologous rectus fascial sling (TO‐AFS) and 94.6% (53/56) for those with TVT‐O (p = 0.47). No difference was determined between the TO‐AFS and TVT‐O groups in respect of the ICIQ‐SF and QoL scores at 2 years postoperatively (p = 0.87). There were five postoperative complications in the TO‐AFS group (one urinary retention, one hematoma at suprapubic incision line, and three intermittent groin pains) and four in the TVT‐O group (four persistent groin pain) (p = 0.98).Conclusions: The objective cure rates of the 24‐month outcomes of TO‐AFS indicate that this novel surgical technique seems to be a highly effective, safe, and feasible procedure for the treatment of SUI, but further studies including long‐term follow‐up are mandatory to confirm these preliminary data.
- Open Access
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 35 (9) , e202000905
The examination of the nephroprotective effect of montelukast sodium and N-acetylcysteine ın renal ıschemia with dimercaptosuccinic acid imaging in a placebo-controlled rat model
Purpose To determine the nephroprotective effect of NAC and Montelukast Sodium administration against the development of renal damage associated with long warm renal ischemia. Methods Twenty-seven rats were randomly divided into 3 study groups, which received NAC, montelukast and placebo, and 3 rats were included in the sham-treated control group. Medications were given 3 days before the procedure. DMSA renal scintigraphy was performed before and after surgery. The right renal pedicle was occluded for 45 min to induce ischemia and then subjected to reperfusion for 6 h (I/R groups). Results On pathological examination, the mean pathological scores of the montelukast and NAC groups were significantly lower than those of the placebo group. (p <0.05). In biochemical examination, significant differences were found in all parameter levels between the placebo group and the montelukast and NAC groups. (p <0.05) When postoperative DMSA renal scintigraphy measurements and renal function levels were compared, significant differences were found between the montelukast and NAC groups and the placebo and sham groups. Conclusion The administration of NAC and montelukast sodium was seen to have a nephroprotective effect against the development of renal damage associated with warm renal ischemia.
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 35 (9) , e202000905
Open AccessThe examination of the nephroprotective effect of montelukast sodium and N-acetylcysteine ın renal ıschemia with dimercaptosuccinic acid imaging in a placebo-controlled rat model
Purpose To determine the nephroprotective effect of NAC and Montelukast Sodium administration against the development of renal damage associated with long warm renal ischemia. Methods Twenty-seven rats were randomly divided into 3 study groups, which received NAC, montelukast and placebo, and 3 rats were included in the sham-treated control group. Medications were given 3 days before the procedure. DMSA renal scintigraphy was performed before and after surgery. The right renal pedicle was occluded for 45 min to induce ischemia and then subjected to reperfusion for 6 h (I/R groups). Results On pathological examination, the mean pathological scores of the montelukast and NAC groups were significantly lower than those of the placebo group. (p <0.05). In biochemical examination, significant differences were found in all parameter levels between the placebo group and the montelukast and NAC groups. (p <0.05) When postoperative DMSA renal scintigraphy measurements and renal function levels were compared, significant differences were found between the montelukast and NAC groups and the placebo and sham groups. Conclusion The administration of NAC and montelukast sodium was seen to have a nephroprotective effect against the development of renal damage associated with warm renal ischemia.
- Open Access
- 1 January 2013
- Published by Wiley in The Scientific World Journal
- Vol. 2013 (1) , 604361
Comparison of Ultrasonic and Pneumatic Intracorporeal Lithotripsy Techniques during Percutaneous Nephrolithotomy
Objectives. To compare the effectiveness and safety of ultrasonic and pneumatic lithotripters in the treatment of renal stone disease. Materials and Methods. A total of 227 consecutive percutaneous nephrolithotomy procedures for renal calculi were performed. In 107 patients ultrasonic lithotriptors were used (group I) and in 83 patients pneumatic lithotriptors were used (group II). In the remaining 37 patients, stones were managed with both pneumatic and ultrasonic lithotripters. Follow‐up studies included intravenous urography (IVU) and/or computed tomography (CT). Results. The mean operative time and duration of hospitalization were similar between the groups. In the ultrasonic treatment group, 100 (96.9%) patients were stone‐free on postoperative day 1 and 5 (4.6%) went on to undergo an additional treatment modality, resulting in a total stone‐free rate of 97.2%. In the pneumatic lithotripsy group, 68 (81.9%) patients were stone‐free after the primary procedure on the first day and 15 (18.1%) went on to undergo an additional treatment modality, resulting in a stone‐free rate of 91.5%. The final stone‐free rates at 3 months postoperatively in groups I, II, and III were 97.2%, 91.5%, and 87.9%, respectively (P = 0.826). Conclusions. We conclude that both ultrasonic and pneumatic lithotripters are effective and safe for intracorporeal lithotripsy. However, the ultrasonic lithotripter provides higher stone‐free rates with similar morbidity compared with pneumatic devices.
- 1 January 2013
- Published by Wiley in The Scientific World Journal
- Vol. 2013 (1) , 604361
Open AccessComparison of Ultrasonic and Pneumatic Intracorporeal Lithotripsy Techniques during Percutaneous Nephrolithotomy
Objectives. To compare the effectiveness and safety of ultrasonic and pneumatic lithotripters in the treatment of renal stone disease. Materials and Methods. A total of 227 consecutive percutaneous nephrolithotomy procedures for renal calculi were performed. In 107 patients ultrasonic lithotriptors were used (group I) and in 83 patients pneumatic lithotriptors were used (group II). In the remaining 37 patients, stones were managed with both pneumatic and ultrasonic lithotripters. Follow‐up studies included intravenous urography (IVU) and/or computed tomography (CT). Results. The mean operative time and duration of hospitalization were similar between the groups. In the ultrasonic treatment group, 100 (96.9%) patients were stone‐free on postoperative day 1 and 5 (4.6%) went on to undergo an additional treatment modality, resulting in a total stone‐free rate of 97.2%. In the pneumatic lithotripsy group, 68 (81.9%) patients were stone‐free after the primary procedure on the first day and 15 (18.1%) went on to undergo an additional treatment modality, resulting in a stone‐free rate of 91.5%. The final stone‐free rates at 3 months postoperatively in groups I, II, and III were 97.2%, 91.5%, and 87.9%, respectively (P = 0.826). Conclusions. We conclude that both ultrasonic and pneumatic lithotripters are effective and safe for intracorporeal lithotripsy. However, the ultrasonic lithotripter provides higher stone‐free rates with similar morbidity compared with pneumatic devices.